Global Infectious Diseases Diagnostic Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Infectious Diseases Diagnostic Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Infectious Diseases Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Urine
  • 1.4.3 Blood
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Infectious Diseases Diagnostic Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and Trauma Centers
  • 1.5.3 Diagnostic Laboratories
  • 1.5.4 Rehabilitation Centers
• 1.6 Coronavirus Disease 2019 (Covid-19): Infectious Diseases Diagnostic Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Infectious Diseases Diagnostic Industry
    • 1.6.1.1 Infectious Diseases Diagnostic Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Infectious Diseases Diagnostic Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Infectious Diseases Diagnostic Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Infectious Diseases Diagnostic Market Perspective (2015-2026)
• 2.2 Infectious Diseases Diagnostic Growth Trends by Regions
  • 2.2.1 Infectious Diseases Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Infectious Diseases Diagnostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Infectious Diseases Diagnostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Infectious Diseases Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Infectious Diseases Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Infectious Diseases Diagnostic Players by Market Size
  • 3.1.1 Global Top Infectious Diseases Diagnostic Players by Revenue (2015-2020)
  • 3.1.2 Global Infectious Diseases Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Infectious Diseases Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Infectious Diseases Diagnostic Market Concentration Ratio
  • 3.2.1 Global Infectious Diseases Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Infectious Diseases Diagnostic Revenue in 2019
• 3.3 Infectious Diseases Diagnostic Key Players Head office and Area Served
• 3.4 Key Players Infectious Diseases Diagnostic Product Solution and Service
• 3.5 Date of Enter into Infectious Diseases Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Infectious Diseases Diagnostic Historic Market Size by Type (2015-2020)
• 4.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Type (2021-2026)

5 Infectious Diseases Diagnostic Breakdown Data by Application (2015-2026)

• 5.1 Global Infectious Diseases Diagnostic Market Size by Application (2015-2020)
• 5.2 Global Infectious Diseases Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Infectious Diseases Diagnostic Market Size (2015-2020)
• 6.2 Infectious Diseases Diagnostic Key Players in North America (2019-2020)
• 6.3 North America Infectious Diseases Diagnostic Market Size by Type (2015-2020)
• 6.4 North America Infectious Diseases Diagnostic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Infectious Diseases Diagnostic Market Size (2015-2020)
• 7.2 Infectious Diseases Diagnostic Key Players in Europe (2019-2020)
• 7.3 Europe Infectious Diseases Diagnostic Market Size by Type (2015-2020)
• 7.4 Europe Infectious Diseases Diagnostic Market Size by Application (2015-2020)

8 China

• 8.1 China Infectious Diseases Diagnostic Market Size (2015-2020)
• 8.2 Infectious Diseases Diagnostic Key Players in China (2019-2020)
• 8.3 China Infectious Diseases Diagnostic Market Size by Type (2015-2020)
• 8.4 China Infectious Diseases Diagnostic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Infectious Diseases Diagnostic Market Size (2015-2020)
• 9.2 Infectious Diseases Diagnostic Key Players in Japan (2019-2020)
• 9.3 Japan Infectious Diseases Diagnostic Market Size by Type (2015-2020)
• 9.4 Japan Infectious Diseases Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Infectious Diseases Diagnostic Market Size (2015-2020)
• 10.2 Infectious Diseases Diagnostic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Infectious Diseases Diagnostic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Infectious Diseases Diagnostic Market Size by Application (2015-2020)

11 India

• 11.1 India Infectious Diseases Diagnostic Market Size (2015-2020)
• 11.2 Infectious Diseases Diagnostic Key Players in India (2019-2020)
• 11.3 India Infectious Diseases Diagnostic Market Size by Type (2015-2020)
• 11.4 India Infectious Diseases Diagnostic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Infectious Diseases Diagnostic Market Size (2015-2020)
• 12.2 Infectious Diseases Diagnostic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Infectious Diseases Diagnostic Market Size by Type (2015-2020)
• 12.4 Central & South America Infectious Diseases Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Becton Dickinson & Company
  • 13.1.1 Becton Dickinson & Company Company Details
  • 13.1.2 Becton Dickinson & Company Business Overview and Its Total Revenue
  • 13.1.3 Becton Dickinson & Company Infectious Diseases Diagnostic Introduction
  • 13.1.4 Becton Dickinson & Company Revenue in Infectious Diseases Diagnostic Business (2015-2020))
  • 13.1.5 Becton Dickinson & Company Recent Development
• 13.2 Cepheid, Inc.
  • 13.2.1 Cepheid, Inc. Company Details
  • 13.2.2 Cepheid, Inc. Business Overview and Its Total Revenue
  • 13.2.3 Cepheid, Inc. Infectious Diseases Diagnostic Introduction
  • 13.2.4 Cepheid, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.2.5 Cepheid, Inc. Recent Development
• 13.3 Abbott Laboratories
  • 13.3.1 Abbott Laboratories Company Details
  • 13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
  • 13.3.3 Abbott Laboratories Infectious Diseases Diagnostic Introduction
  • 13.3.4 Abbott Laboratories Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.3.5 Abbott Laboratories Recent Development
• 13.4 bioMerieux SA
  • 13.4.1 bioMerieux SA Company Details
  • 13.4.2 bioMerieux SA Business Overview and Its Total Revenue
  • 13.4.3 bioMerieux SA Infectious Diseases Diagnostic Introduction
  • 13.4.4 bioMerieux SA Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.4.5 bioMerieux SA Recent Development
• 13.5 Hologic, Inc.
  • 13.5.1 Hologic, Inc. Company Details
  • 13.5.2 Hologic, Inc. Business Overview and Its Total Revenue
  • 13.5.3 Hologic, Inc. Infectious Diseases Diagnostic Introduction
  • 13.5.4 Hologic, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.5.5 Hologic, Inc. Recent Development
• 13.6 Danaher Corporation
  • 13.6.1 Danaher Corporation Company Details
  • 13.6.2 Danaher Corporation Business Overview and Its Total Revenue
  • 13.6.3 Danaher Corporation Infectious Diseases Diagnostic Introduction
  • 13.6.4 Danaher Corporation Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.6.5 Danaher Corporation Recent Development
• 13.7 Thermo Fisher Scientific, Inc.
  • 13.7.1 Thermo Fisher Scientific, Inc. Company Details
  • 13.7.2 Thermo Fisher Scientific, Inc. Business Overview and Its Total Revenue
  • 13.7.3 Thermo Fisher Scientific, Inc. Infectious Diseases Diagnostic Introduction
  • 13.7.4 Thermo Fisher Scientific, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.7.5 Thermo Fisher Scientific, Inc. Recent Development
• 13.8 Roche Diagnostics
  • 13.8.1 Roche Diagnostics Company Details
  • 13.8.2 Roche Diagnostics Business Overview and Its Total Revenue
  • 13.8.3 Roche Diagnostics Infectious Diseases Diagnostic Introduction
  • 13.8.4 Roche Diagnostics Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.8.5 Roche Diagnostics Recent Development
• 13.9 Alera Inc.
  • 13.9.1 Alera Inc. Company Details
  • 13.9.2 Alera Inc. Business Overview and Its Total Revenue
  • 13.9.3 Alera Inc. Infectious Diseases Diagnostic Introduction
  • 13.9.4 Alera Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.9.5 Alera Inc. Recent Development
• 13.10 DiaSorin S.p.A.
  • 13.10.1 DiaSorin S.p.A. Company Details
  • 13.10.2 DiaSorin S.p.A. Business Overview and Its Total Revenue
  • 13.10.3 DiaSorin S.p.A. Infectious Diseases Diagnostic Introduction
  • 13.10.4 DiaSorin S.p.A. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 13.10.5 DiaSorin S.p.A. Recent Development
• 13.11 Quidel Corporation
  • 10.11.1 Quidel Corporation Company Details
  • 10.11.2 Quidel Corporation Business Overview and Its Total Revenue
  • 10.11.3 Quidel Corporation Infectious Diseases Diagnostic Introduction
  • 10.11.4 Quidel Corporation Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 10.11.5 Quidel Corporation Recent Development
• 13.12 Bio-Rad Laboratories, Inc.
  • 10.12.1 Bio-Rad Laboratories, Inc. Company Details
  • 10.12.2 Bio-Rad Laboratories, Inc. Business Overview and Its Total Revenue
  • 10.12.3 Bio-Rad Laboratories, Inc. Infectious Diseases Diagnostic Introduction
  • 10.12.4 Bio-Rad Laboratories, Inc. Revenue in Infectious Diseases Diagnostic Business (2015-2020)
  • 10.12.5 Bio-Rad Laboratories, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer